01099 SINOPHARM
Closed Add to Porfolio| Date of Relevant Event | Name of Substantial Shareholder | Long Position (%)* | Change (%) | Short Position (%)* | Change (%) | Lending Pool (%)* | Change (%) | Remarks |
|---|---|---|---|---|---|---|---|---|
| 2019-01-02 | BlackRock, Inc. | 84206929 (7.06%) |
+7.06 | 0 (0.00%) |
0 (0.00%) |
Details | ||
| 2018-12-07 | Oppenheimer Developing Markets Fund | 142587200 (11.95%) |
-0.99 | 0 (0.00%) |
0 (0.00%) |
Details | ||
| 2018-12-07 | OppenheimerFunds, Inc. | 166793064 (13.98%) |
-0.94 | 0 (0.00%) |
0 (0.00%) |
Details | ||
| 2018-10-19 | JPMorgan Chase & Co. | 250672887 (21.01%) |
+0.08 | 3354632 (0.28%) |
230041040 (19.28%) |
+0.05 | Details | |
| 2018-10-09 | Citigroup Inc. | 59404253 (4.98%) |
-0.04 | 865159 (0.07%) |
56186593 (4.71%) |
Details | ||
| 2018-06-20 | FIL Limited | 59125200 (4.96%) |
-0.06 | 0 (0.00%) |
0 (0.00%) |
Details | ||
| 2018-01-17 | Matthews International Capital Management, LLC | 71724400 (6.01%) |
+0.98 | 0 (0.00%) |
0 (0.00%) |
Details |
Last Update﹕2019-01-07
(%)* - % of issued share capital
(%)* - % of issued share capital
